Dr Vanderfaeillie is a pediatrician working in CHU Saint-Pierre, Brussels.
After her training in Pediatrics and Tropical Medicine in Belgium, Anna worked abroad - Haiti and Congo - where she discovered sickle cell anemia. Back in Belgium, she had the opportunity to begin a sickle cell consultation in the CHU Saint-Pierre hospital.
She is the chair of the Red Blood Cell Disorders Committee.
Dr Labarque is Adjunct Medical Head in Pediatric Hematology and Oncology at UZ Leuven since 2011.
She has a special interest in benign hematology.
She is also part-time assistant professor at the Faculty of Medicine, Catholic University of Leuven (KUL) since 2012.
She co-chairs the Red Blood Cell Disorders Committee.
Pr Gulbis is a physician specialised in Clinical Biology. She has joined the Academic Hospital Erasme in Brussels, Belgium where she has developed a reference laboratory centre for the diagnosis, prevention and follow-up of patients with hereditary red blood cells disorders and has built in this domain a collaboration with the ULB Center of Human Genetics. She has contributed to the implementation of a national network of health professionals on non-oncological red blood cells disorders through the Belgian Hematology Society (www.bhs.be) and was working for more than 10 years for a European network on rare anaemias (www.enerca.org<http://www.enerca.org/>). Since March 2017 she is the co-coordinator of the ERN EuroBloodNet (www.eurobloodnet.eu<http://www.eurobloodnet.eu/>). Her experience has also been based on grants for research projects in Africa i.e. Burkina Faso, Mali and Democratic Republic of Congo.
She is currently the Medical Director of a clinical laboratory working for 5 university hospitals in Brussels (The Brussels Academic Hospital Lab - LHUB-ULB).
Sarah Wambacq is Data Manager in the Pediatric Hemato-Oncology department of HUDERF, Brussels.
She is in charge of the general management support of the unit.
In addition to being the Project Manager of the national SCD Registry, she is in charge of the data management of the HSCT EBMT Registry, the cancer registration, the Late Effect project. She collaborates in the JACIE accreditation of the transplant center.
Dr Begu is Deputy Head of clinic in the ophtalmology department of Brugmann hospital in Brussels.
She is specialized in retinal pathology.
Dr Allali is a pediatrician and works as hospital practitioner in the department of general pediatrics and infectious diseases in a reference center for Sickle Cell Disease, thalassaemia and other rare Red Blood Cell Diseases and erythropoiesis anomalies in Paris (Sickle Cell Center, Université de Paris, Hôpital Necker-Enfants malades, Groupe Hospitalier AP-HP. Centre-Université de Paris).
Ms. Adebayo is a PhD Fellow-FWO Aspirant at the Center of Molecular and Vascular Biology, Department of Cardiovascular Sciences of the Katholieke Universiteit Leuven (KUL).
Her PhD research focuses on the renal complications of sickle cell disease, especially in the paediatric population.
Pierre-Emmanuel Gleizes is a professor of molecular and cellular biology at the University of Toulouse/Paul Sabatier and a research group leader at the Centre for Integrative Biology in Toulouse.
His work focuses on the mechanisms of ribosome biogenesis in humans and on the pathological disorders associated to defects in ribosome synthesis. He has pioneered the study of ribosome synthesis defects in Diamond-Blackfan anemia and has been collaborating with various clinical geneticists in Europe and in the USA to characterize the functional impact of mutated ribosomal protein genes linked to the disease.
He is currently coordinating the RiboEurope European program (EJPRD) on the genetics and the diagnosis of DBA.
P-E. Gleizes was awarded the DBA Pioneer Award by the American DBA Foundation in 2014.
Dr Lambilliotte is a paediatrician, and is Head of the ambulatory paediatric haematology-oncology unit in the Lille University Hospital.
She is a referral physician for neonatal screening of hemoglobinopathy in the north of France, and for the Red Cell Rare Disease Reference Center in Lille.
She is also the medical coordinator of PEDONCO, a regional group of care in Haemato-Oncology for children in the north of France.
Dr Lambilliotte is a Society member of the Société Française des Cancers de l’Enfant, the Société d’immunologie et d’hématologie pédiatrique, and a member of the Club du Globule Rouge.
Anne-Sophie Adam studied pharmacy at the Université Libre de Bruxelles (ULB). After her graduation in 2014, she specialized in Clinical Laboratory Medicine.
In 2019, she joined the clinical chemistry department of the LHUB-ULB where her main clinical activities focus on hereditary Red Blood Cell Disorders, including the newborn screening of Sickle Cell Disease and the erythrocyte membranopathies for which the LHUB-ULB became the National Reference Laboratory in 2019.
She is also a member of the Red Blood Cell Disorder Committee of the Belgian Hematology Society (BHS).
Dr Dhedin works in Saint-Louis hospital in Paris, in a hematology unit dedicated to adolescents and young adults. She is responsable for patients treated with allograft.
She will share with us the experience of her unit about bone marrow transplant in Sickle Cell adolescent and adult patients: the results and the specificities.
Dr Therer is a pediatric assistant in the first year of specialization, currently working at the Marie-Curie hospital in Charleroi.
She devoted her end-of-medical studies work to Sickle Cell Disease, mentored by Dr Ferster, in HUDERF (Brussels).
Dr Thierry Roumeguère graduated from the René Descartes Medical School of the Paris V University in 1989 and was certified as a specialist in Urology at the Université Libre de Bruxelles (ULB) in 1999. He is Professor of Urology and Lecturer at the Faculty of medicine of ULB. He has been Head of the Department of Urology at the Erasme hospital since 2010.
He is a member of the scientific committee of the Belgian Society of Urology and of the Belgian working group in Oncology and Functional Urology for the Belgian Association of Urology. He is also a member of several scientific societies (EAU, AUA, AFU, ASCO, EORTC, ISSM, ESSM) and served as member of the scientific committee of the European Society for Sexual Medicine. He is a reviewer for several journals such as European Urology, Journal of Urology, Journal of Clinical Oncology, British Journal of Urology International, International Journal of Impotence Research, Journal of Sexual Medicine.
He is adjunct-Editor for Progrès en Urologie. He has a major interest for fundamental research on the intriguing role of myeloperoxidase in prostate diseases and for the implication of erectile dysfunction on endothelial function and cardiovascular diseases. He is the author or co-author of more than 200 peer-reviewed publications. He is currently involved in several studies in the fields of Oncology (prostate, bladder and kidney cancers), as well as in Peyronie’s disease and penile implants.
Dr Marie-Agnès AZERAD is Head of Clinic in the haematology department in Liège (Citadelle).
She is an active member of the BHS Red Blood Cell Disease Group.
Dr Olivier Ketelslegers is a physician specialised in Clinical Biology. He works in the department of Laboratory Medicine, CHR de la Citadelle, Liège.
He is a member of the Red Blood Cell Disorder Committee of the Belgian Hematology Society (BHS).